Bolt Biotherapeutics
ID: 5835073Bolt Biotherapeutics is developing its novel BoltbodyTM platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).
2
Funding Rounds
$147.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ed*** G. En****** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ed*** G. En****** | - | - | - |
| Ma****** G. Sh** | - | - | - |
| Ri***** Mi**** | - | - | - |
| Ra***** Sc******* |
|
- | |
| Fr*** D. Le* | - | - | - |
Funding series
Funding Series Analysis
The company Bolt Biotherapeutics has raised a total of $93.5m in funding over 2 rounds.
Key Insights:
- Bolt Biotherapeutics, Inc. Series C round, July 2020: $93.5m
- Bolt Biotherapeutics Series B round, February 2019: $54m
Industries
Bolt Biotherapeutics is active in the following industries: